InvestorsHub Logo
Followers 0
Posts 148
Boards Moderated 0
Alias Born 03/18/2013

Re: Hspooner post# 5089

Thursday, 04/25/2013 4:48:23 PM

Thursday, April 25, 2013 4:48:23 PM

Post# of 429497
You're not taking into account stocking revenue.

MKM Partner's LeCroy: "...would imply Q1 Vascepa sales of approximately $2.2M and Q2 of around $11M. So, while the consensus estimates still appear to be slightly high, LeCroy thinks that with stocking, they still could be attainable..."

1st quarter earnings 2.32 million on 9659 scripts add 2.4 million for April we get 4.7 million add 15% under reporting and you get 5.4 million. Now if that was the number what would WS do?

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News